Today’s AI Top Pick: BSX

8/5/2026 · Model Aligned screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · BSX61%361 resolved forecasts · 45d window · verify →

Today's pick · Model AlignedBSXBUY NOW8.6 / 108/5/2026

Boston Scientific (BSX) is the cleanest full-conviction buy in this pool: bullish_prob = 1.0, near_term = 0.8, and every single timeframe's Kronos forecast is positive with exceptional magnitudes — 4h fc_mid/long +52.07%/+58.99%, 1d fc_short/mid/long +12.79%/+46.63%/+73.15%, and 1wk fc_long +22.95%. That is genuine multi-timeframe agreement with the mid/long horizons carrying most of the weight, exactly the setup this screen is designed to surface. The usual objection would be that BSX sits at 100% position-in-range on 1h/4h/1d — but the weekly tells the real story: it is only 20.47% of its 21-bar range with a -29.13% drawdown from the weekly high. In other words, the short-term timeframes are breaking out from a deeply oversold weekly base, not blowing off a top. This is the ideal 'coming off the lows into a fresh trend' geometry rather than a chase. Fundamentals reinforce it: PE 19.9, fwdPE 14.32, ROE 15.52, profit margin 17.5%, sales +13.53% YoY, operating margin 21.8%, recom 1.45 (strong buy), and 25.1% analyst upside even AFTER the recent price-target trim. The main news landmine is the 8/4 headline that BSX's price target was cut 14.59% to $68.21 — worth calling out, but it is a trim, not a downgrade or a guidance cut, and $68.21 still implies ~38% upside from spot $49.24. Compared to LII (fresh guidance cut, avoid), STRL (weekly fc_long -71.57%), RMBS (weekly fc_long -48.02%), CRMT (exploring asset sales, -86% YTD) and DY (all-timeframe negative forecasts), BSX has no comparable landmine. Why today and not wait? The 4h/1d are printing breakout closes with fc_short still positive (+1.72% and +12.79%), meaning the model expects continuation, not a mean-reversion pullback. Waiting risks entering after another leg. Size the position with a defined stop under the recent breakout base rather than trying to time a pullback that the forecast says may not come.

Entry zone

$48.50–$49.60 (spot $49.24; add on any intraday dip toward the 1h breakout shelf)

Stop loss

$46.20 (about -6.2%, below the 1h/4h breakout base — a close below invalidates the 'coming off weekly lows' thesis)

First target

$55.25 (+12%, aligned with 1d fc_short +12.79% and 1wk fc_long +22.95%)

Longer target

$68.20 (+38%, matches the trimmed but still bullish analyst PT and the 1d fc_long +73.15% envelope)

Risks

Short-term timeframes at 100% of 21-bar range — a 3–5% mean-reversion pullback to $46–47 is a live risk before continuation
Sell-side just trimmed the PT by 14.59% on 8/4; further estimate cuts would undercut the forecast
1wk fc_short is -4.74%, so on a weekly-close basis the very short term is not confirmed yet
Perf Year -54.03% and YTD -48.52% show BSX is a fallen-angel rebound trade, not a trend leader — supply from underwater holders is real
Healthcare sector regulatory/reimbursement headline risk is always present for medical devices

Honorable mentions

CMCSAbullish_prob=1, all four TFs have positive forecasts with the 1wk fc_long a standout +33.12%, PE 8.07 / fwdPE 6.89 is deep value, and no negative catalysts. 1d at 100% of range is the only knock; more of a slow-compounder than BSX's asymmetric setup.

ONONFundamental score 7.25 (PEG 0.45, sales +36%, ROE 16.48), bullish_prob=1, and 1d/4h/1wk all forecast positive with position-in-range middling (not chasing). Peter Lynch 'ten-bagger' article and earnings next week are two-way catalysts — lower conviction than BSX because 1h fc_long is -4.54%.

Full ranking (24)

#	Symbol	Verdict	Score	Read
1	BSX	BUY NOW	8.6	Multi-TF alignment with 1d fc_long +73% and 4h fc_long +59% off a weekly base at 20% of range — best forecast magnitude in the pool.
2	CMCSA	BUY NOW	7.6	Deep-value telecom (PE 8, fwdPE 6.89) with 1wk fc_long +33.12% and all TFs bullish; safest compounder in the list.
3	ONON	BUY NOW	7.2	Growth+value combo (PEG 0.45, sales +36%) with clean multi-TF bullish signals and middling position-in-range.
4	RDDT	BUY PULLBACK	6.8	Fresh guidance raise and 'shares soaring' catalyst, but 1wk fc_mid/long -33%/-30% flags mean-reversion risk after the pop.
5	NUS	BUY PULLBACK	6.4	Tiny cap with 1d fc_short/mid +28.68%/+65.61% and PE 4.87, but 1h forecasts turning negative and sales -14% YoY.
6	SRE	BUY NOW	6.2	Deeply oversold utility (RSI 31.9, pos 0% on 4h/1d/1wk) with positive short-term forecasts across all TFs.
7	PPL	BUY NOW	6.0	Data-center power plant catalyst plus positive short/mid forecasts on every TF; conservative utility play.
8	LINK-USD	BUY NOW	5.9	1wk fc_long +111.39% with Swift partnership and $14.5B bridge migration catalyst; bullish_prob=1 crypto beta.
9	PAAS	WAIT	5.6	Great fundamentals (fund score 8, ROE 20.8) but 1h/4h/1d forecasts are marginal and 1wk fc_long -63%.
10	AU	WAIT	5.3	Gold miner at 100% of 4h/1d range with all longer forecasts negative (1wk fc_long -73.95%) — chase risk.
11	CRV-USD	WAIT	5.2	1wk fc_long +201.52% is eye-popping but 1wk fc_short -36.6% suggests pain first; whale accumulation narrative.
12	PSN	WAIT	5.0	bullish_prob=1 with 1d fc_mid +30.43% but PT just cut by Goldman and near_term_bullish only 0.2.
13	YUM	WAIT	4.7	1wk position 0.48% is oversold but every weekly forecast is negative; Pizza Hut divestiture headline is a two-way.
14	HWKN	WAIT	4.5	1h/4h/1d forecasts positive but 1wk fc_mid/long -23.68%/-22.64% and just missed Q1 EPS.
15	RSG	WAIT	4.3	Defensive name at bottom of daily range but near_term_bullish only 0.2 and weekly forecasts negative.
16	ULS	WAIT	4.0	Oversold (RSI 29.4, pos 0% weekly) but 1d/1wk forecasts turning negative; post-earnings digestion needed.
17	WMT	WAIT	3.7	Weekly forecasts sharply negative (-32%/-38% mid/long) and Oppenheimer just downgraded — wait.
18	LIN	WAIT	3.5	Two PT cuts this week and 1wk fc_long -12.78% offset the mild oversold bounce setup.
19	BKE	WAIT	3.0	At 100% of range on 1h/4h/1d — full chase, and 1wk fc_mid -22.69%.
20	RMBS	AVOID	2.7	bullish_prob 0.2 and 1wk fc_long -48.02% after margin-worry headline — broken.
21	LII	AVOID	2.4	Fresh 2026 EPS guidance cut on 7/31; forecast strength doesn't overcome fundamental deterioration.
22	STRL	AVOID	2.0	bullish_prob 0 and 1wk fc_long -71.57%; post-earnings weekly forecasts collapse.
23	DY	AVOID	1.5	bullish_prob 0, near_term 0, and 1d/1wk fc_long -19%/-56% — the model actively dislikes this one.
24	CRMT	AVOID	0.6	Ranking artifact — $27M micro-cap exploring asset sales, -86.9% YTD, negative margins; the huge forecast is noise on a broken chart.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord